Valves aortiques percutanées: résultats actuels et perspectives

Translated title of the contribution: Percutaneous aortic valve implantation: Results and perspectives

Thomas Hovasse, Thierry Lefevre, Marie claude Morice, Bernard Chevalier, Kentaro Hayashida, Philippe Garot, Mauro Romano, Patrick Donzeau-Gouge, Arnaud Farge, Erik Bouvier, Bertrand Cormier

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

As the French population is aging, a growing number of elderly patients with symptomatic severe aortic stenosis are going to require therapeutic management. Approximately 30 to 40% of these patients do not undergo surgical treatment and a high proportion is considered to be at high risk for surgery. The transluminal aortic valve implantation technique has been increasingly used over the past few years, thus providing a solution to a major therapeutic issue in our industrialized countries. While the cardiology community was rapidly convinced of its efficacy, remaining doubts regarding the outcome of this technique in terms of mortality were erased by the recent publication of results achieved in cohort B of the Partner US trial. This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects.

Original languageFrench
Pages (from-to)732-739
Number of pages8
JournalPresse Medicale
Volume40
Issue number7-8
DOIs
Publication statusPublished - 2011 Jul
Externally publishedYes

Fingerprint

Aortic Valve
Aortic Valve Stenosis
Cardiology
Developed Countries
Patient Selection
Therapeutics
Mortality
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hovasse, T., Lefevre, T., Morice, M. C., Chevalier, B., Hayashida, K., Garot, P., ... Cormier, B. (2011). Valves aortiques percutanées: résultats actuels et perspectives. Presse Medicale, 40(7-8), 732-739. https://doi.org/10.1016/j.lpm.2011.02.037

Valves aortiques percutanées : résultats actuels et perspectives. / Hovasse, Thomas; Lefevre, Thierry; Morice, Marie claude; Chevalier, Bernard; Hayashida, Kentaro; Garot, Philippe; Romano, Mauro; Donzeau-Gouge, Patrick; Farge, Arnaud; Bouvier, Erik; Cormier, Bertrand.

In: Presse Medicale, Vol. 40, No. 7-8, 07.2011, p. 732-739.

Research output: Contribution to journalArticle

Hovasse, T, Lefevre, T, Morice, MC, Chevalier, B, Hayashida, K, Garot, P, Romano, M, Donzeau-Gouge, P, Farge, A, Bouvier, E & Cormier, B 2011, 'Valves aortiques percutanées: résultats actuels et perspectives', Presse Medicale, vol. 40, no. 7-8, pp. 732-739. https://doi.org/10.1016/j.lpm.2011.02.037
Hovasse T, Lefevre T, Morice MC, Chevalier B, Hayashida K, Garot P et al. Valves aortiques percutanées: résultats actuels et perspectives. Presse Medicale. 2011 Jul;40(7-8):732-739. https://doi.org/10.1016/j.lpm.2011.02.037
Hovasse, Thomas ; Lefevre, Thierry ; Morice, Marie claude ; Chevalier, Bernard ; Hayashida, Kentaro ; Garot, Philippe ; Romano, Mauro ; Donzeau-Gouge, Patrick ; Farge, Arnaud ; Bouvier, Erik ; Cormier, Bertrand. / Valves aortiques percutanées : résultats actuels et perspectives. In: Presse Medicale. 2011 ; Vol. 40, No. 7-8. pp. 732-739.
@article{a623487fae3b4bab8927f3a55ddfd80f,
title = "Valves aortiques percutan{\'e}es: r{\'e}sultats actuels et perspectives",
abstract = "As the French population is aging, a growing number of elderly patients with symptomatic severe aortic stenosis are going to require therapeutic management. Approximately 30 to 40{\%} of these patients do not undergo surgical treatment and a high proportion is considered to be at high risk for surgery. The transluminal aortic valve implantation technique has been increasingly used over the past few years, thus providing a solution to a major therapeutic issue in our industrialized countries. While the cardiology community was rapidly convinced of its efficacy, remaining doubts regarding the outcome of this technique in terms of mortality were erased by the recent publication of results achieved in cohort B of the Partner US trial. This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects.",
author = "Thomas Hovasse and Thierry Lefevre and Morice, {Marie claude} and Bernard Chevalier and Kentaro Hayashida and Philippe Garot and Mauro Romano and Patrick Donzeau-Gouge and Arnaud Farge and Erik Bouvier and Bertrand Cormier",
year = "2011",
month = "7",
doi = "10.1016/j.lpm.2011.02.037",
language = "French",
volume = "40",
pages = "732--739",
journal = "Presse Medicale",
issn = "0755-4982",
publisher = "Elsevier Masson",
number = "7-8",

}

TY - JOUR

T1 - Valves aortiques percutanées

T2 - résultats actuels et perspectives

AU - Hovasse, Thomas

AU - Lefevre, Thierry

AU - Morice, Marie claude

AU - Chevalier, Bernard

AU - Hayashida, Kentaro

AU - Garot, Philippe

AU - Romano, Mauro

AU - Donzeau-Gouge, Patrick

AU - Farge, Arnaud

AU - Bouvier, Erik

AU - Cormier, Bertrand

PY - 2011/7

Y1 - 2011/7

N2 - As the French population is aging, a growing number of elderly patients with symptomatic severe aortic stenosis are going to require therapeutic management. Approximately 30 to 40% of these patients do not undergo surgical treatment and a high proportion is considered to be at high risk for surgery. The transluminal aortic valve implantation technique has been increasingly used over the past few years, thus providing a solution to a major therapeutic issue in our industrialized countries. While the cardiology community was rapidly convinced of its efficacy, remaining doubts regarding the outcome of this technique in terms of mortality were erased by the recent publication of results achieved in cohort B of the Partner US trial. This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects.

AB - As the French population is aging, a growing number of elderly patients with symptomatic severe aortic stenosis are going to require therapeutic management. Approximately 30 to 40% of these patients do not undergo surgical treatment and a high proportion is considered to be at high risk for surgery. The transluminal aortic valve implantation technique has been increasingly used over the past few years, thus providing a solution to a major therapeutic issue in our industrialized countries. While the cardiology community was rapidly convinced of its efficacy, remaining doubts regarding the outcome of this technique in terms of mortality were erased by the recent publication of results achieved in cohort B of the Partner US trial. This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects.

UR - http://www.scopus.com/inward/record.url?scp=79959789071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959789071&partnerID=8YFLogxK

U2 - 10.1016/j.lpm.2011.02.037

DO - 10.1016/j.lpm.2011.02.037

M3 - Article

C2 - 21511426

AN - SCOPUS:79959789071

VL - 40

SP - 732

EP - 739

JO - Presse Medicale

JF - Presse Medicale

SN - 0755-4982

IS - 7-8

ER -